Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanomaMichele Maio, Paolo A. Ascierto, Riccardo Danielli et al.|Annals of Oncology|2013Cited by 141
Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma IntergroupWilliam Bruno, Giovanna Bianchi‐Scarrà, Lisa Elefanti et al.|Journal of the American Academy of Dermatology|2016Cited by 40
Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenibPaola Queirolo, Paolo A. Ascierto, Francesco Spagnolo et al.|Oncotarget|2016Cited by 12